XBiotech Inc. filed an 8-K/A to clarify that director Craig Rademaker is a consultant for several Canadian private equity firms focusing on capital markets activities, with the initial report dated June 24, 2025.
AI Assistant
XBIOTECH INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.